30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Train-of-Four monitoring: overestimation

      editorial
      Korean Journal of Anesthesiology
      The Korean Society of Anesthesiologists

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          According to a survey on the use of muscle relaxants, there are a lot of cases where routine monitoring of the neuromuscular junction using a nerve stimulator is not applied, nor is quantitative evaluation of the Train of Four (TOF) performed when using a non-depolarizing muscle relaxant. Moreover, the need for monitoring is itself being questioned [1]. Thus, unless the physician has a special interest in monitoring the effect of muscle relaxants, there is a lack of interest in the correct method of monitoring. Therefore, it is essential to promote the need for accurate monitoring when using muscle relaxants through education, especially when the incomplete block of the neuromuscular junction is in question. Monitoring of the neuromuscular junction can be an effective method in determining the dose and time of administration of muscle relaxants for induction or intubation, especially where deep muscular relaxation is required to repress detrimental reflexes. It is also useful in cases where maintenance of muscle relaxation is continuously required, to identify residual muscle relaxation during recovery from anesthesia, during long periods of mechanical ventilation, or in cases where a motor evoked potential is monitored during surgery. Acceleromyelography (AMG) which employs a TOF-Watch® (TOF-Watch S® or TOF-Watch SX®: upgraded TOF-Watch®, Organon Teknika, the Netherlands) is an easy way to monitor a stimulated neuromuscular junction. And the monitoring device is commercialized, which makes it convenient to monitor the effects of muscle relaxation. It uses the acceleration force of the adductor pollicis muscle, which is the only thenar muscle innervated by the ulnar nerve. It is widely used for its convenience in the clinical field, but it lacks accuracy compared to conventional mechanomyelogrphy (MMG) or electromyelography (EMG), and one should be cautious about an exaggerated estimation of recovery from muscle relaxation [2,3]. There was a discussion on recommendations for good clinical research practice (GCRP) involving neuromuscular blocking agents at the 2005 'International Neuromuscular Meeting' held in Stockholm. This was the third debate of its kind since 1996, and 'Standards' common to all types of neuromuscular monitoring were proposed, and are now considered as a guideline by many researchers [4]. The pattern (rectangular), frequency, amount (supramaximal) of the current, and duration of stimulation are considered important in general, but the most important factor is stabilizing the basic neuromuscular junction in order to keep the stimulated muscle twitch constant, because this can cause a vital bias. Even when the same examiner is measuring the results, it can differ in relation to the method of measurement of stimulated muscle contraction [2]. Furthermore, the results can be dissimilar according to the place of measurement, as between the right arm and the left [5]. There has also been a report stating that when stimulating the same nerve innervating two different muscle groups, the measurement can be similar using two different measuring methods, implying that the muscle responding to the nerve being stimulated can influence the response [6]. In clinical situations where adequate measurement devices are not available, the observer has to evaluate the state of muscle relaxation visually or by touch, and this can show disparities for different methods of evaluation [7]. When using the TOF Watch®, the moving thumb corresponds to the mass and the movement itself acts as momentum. Therefore, fixation of the thumb can influence the results [2]. The TOF often exceeds a 100% ratio after stimulation, and stabilization is needed to minimize this, and the results require correction by comparing them with pre-experiment and post-experiment values [8-10]. Choosing the wrong nerve to be stimulated can result in an exaggerated evaluation of the state of muscle relaxation recovery. A paper published in this months' issue of compares the single twitch (T1) and TOF ratios of the ulnar nerve of one arm and the median nerve on the other arm of the same person simultaneously. The values of TOF ratios and single twitch (ST) ratios of the median nerve are higher than of that of the ulnar nerve by 16.2% and 72.9%, respectively, and they cannot be directly compared. Unlike the ulnar nerve, the median nerve directly stimulates the thenar muscle, making it difficult for it to accurately reflect the neuromuscular junction [11]. Since the measurements obtained were from both arms of the same person, it is thought to have little or no margin of error. But, if it was MMG or EMG and not AMG, and measurements were taken from the same arm, the outcome may have been different. But is expected to have clinical limitations. There are many factors to consider when measured results prove to be abnormal or smaller than expected. On the other hand, misuse of the monitoring device can lead to exaggerated results. The TOF-Watch® has the advantage of being available when needed and can be easily used to show immediate results, but lacks precision in accurately stimulating the ulnar nerve, which ends up causing exaggerated results. Thus, it has to properly stimulate the correct nerve.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: not found

          Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.

          The set of guidelines for good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents, which was developed following an international consensus conference in Copenhagen, has been revised and updated following the second consensus conference in Stockholm in 2005. It is hoped that these guidelines will continue to help researchers in the field and assist the pharmaceutical industry and equipment manufacturers in enhancing the standards of the studies they sponsor.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A survey of current management of neuromuscular block in the United States and Europe.

            Postoperative residual neuromuscular block is a frequent occurrence. Recent surveys of clinical practice in Europe suggest that neuromuscular blocking drugs are often administered without appropriate monitoring. No comparable survey has been undertaken in the United States (US). From this survey, we compared current clinical neuromuscular practice and attitudes between anesthesia practitioners in the US and Europe. We conducted an Internet-based survey among anesthesia practitioners in the US and Europe. The Anesthesia Patient Safety Foundation and the European Society of Anaesthesiology e-mailed all of their active members, inviting them to anonymously answer a series of questions on a dedicated Internet Protocol address-sensitive website. The survey was available online for 60 days. The chi(2) test and Fisher's exact test were used to compare clinical survey items between the 2 cohorts. A total of 2636 completed surveys were received. Most respondents from the US (64.1%) and Europe (52.2%) estimated the incidence of clinically significant postoperative residual neuromuscular weakness to be <1% (P < 0.0001). Routine pharmacologic reversal was less common in Europe than in the US (18% vs 34.2%, respectively; P < 0.0001), and quantitative monitors were available to fewer clinicians in the US (22.7%) than in Europe (70.2%) (P < 0.0001). However, 19.3% of Europeans and 9.4% of Americans never use neuromuscular monitors. Most respondents reported that neither conventional nerve stimulators nor quantitative train-of-four monitors should be part of minimum monitoring standards. Our results suggest a lack of agreement among anesthesia providers about the best way to monitor neuromuscular function. Efforts to improve awareness by developing formal training programs and/or publishing official guidelines on best practices to reduce the incidence of postoperative neuromuscular weakness and patient morbidity are warranted.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9.

              The incidence of residual paralysis, i.e., a mechanomyographic train-of-four (TOF) ratio (T4/T1) less than 0.9, remains frequent. Routine acceleromyography has been proposed to detect residual paralysis in clinical practice. Although acceleromyographic data are easy to obtain, they differ from mechanomyographic data, with which they are not interchangeable. The current study aimed to determine (1) the acceleromyographic TOF ratio that detects residual paralysis with a 95% probability, and (2) the impact of calibration and normalization on this predictive acceleromyographic value. In 60 patients, recovery from neuromuscular block was assessed simultaneously with mechanomyography and acceleromyography. To obtain calibrated acceleromyographic TOF ratios in group A, the implemented calibration modus 2 was activated in the TOF-Watch S; to obtain uncalibrated acceleromyographic TOF ratios in group B, the current was manually set at 50 mA (n = 30 for each). In addition, data in group B were normalized (i.e., dividing the final TOF ratio by the baseline value). The agreement between mechanomyography and acceleromyography was assessed by calculating the intraclass correlation coefficient. Negative predictive values were calculated for detecting residual paralysis from acceleromyographic TOFs of 0.9, 0.95, and 1.0. : For a mechanomyographic TOF of 0.9 or greater, the corresponding acceleromyographic TOF was 0.95 (range, 0.86-1.0), and the negative predictive values for acceleromyographic TOFs of 0.9, 0.95, and 1.0 were 37% (95% CI, 20-56%), 70% (95% CI, 51-85%), and 97% (95% CI, 83-100%), respectively. Group B: Without normalization, an acceleromyographic TOF of 0.97 (range, 0.68-1.18) corresponded to a mechanomyographic TOF of 0.9 or greater, with negative predictive values for acceleromyographic TOFs of 0.9, 0.95, and 1.0 being 40% (95% CI, 23-59%), 60% (95% CI, 41-77%), and 77% (95% CI, 58-90%), respectively. After normalization, an acceleromyographic TOF of 0.89 (range, 0.63-1.06) corresponded to a mechanomyographic TOF of 0.9 or greater, and the negative predictive values of acceleromyographic TOFs of 0.9, 0.95, and 1.0 were 89% (95% CI, 70-98%), 92% (95% CI, 75-99%), and 96% (95% CI, 80-100%), respectively. To exclude residual paralysis reliably when using acceleromyography, TOF recovery to 1.0 is mandatory.
                Bookmark

                Author and article information

                Journal
                Korean J Anesthesiol
                KJAE
                Korean Journal of Anesthesiology
                The Korean Society of Anesthesiologists
                2005-6419
                2005-7563
                May 2011
                31 May 2011
                : 60
                : 5
                : 311-312
                Affiliations
                Department of Anesthesiology and Pain Medicine, Inha University Hospital, Incheon, Korea.
                Author notes
                Corresponding author: Jeong Uk Han, M.D., Ph.D., Department of Anesthesiology and Pain Medicine, Inha University Hospital, 7-206, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-711, Korea. Tel: 82-32-890-3969, Fax: 82-32-881-2476, jwhanan@ 123456inha.ac.kr
                Article
                10.4097/kjae.2011.60.5.311
                3110287
                21716959
                b13f2560-1682-42de-bd90-43b6a3f21510
                Copyright © the Korean Society of Anesthesiologists, 2011

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Categories
                Editorial

                Anesthesiology & Pain management
                Anesthesiology & Pain management

                Comments

                Comment on this article